At a glance
Transformative Technologies for Experimental and Computational RNome Characterization and Functional Analysis is a federal competitive grant from National Institutes of Health for the science & technology sector. Funding is up to $500K. Eligible applicants: Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education; City or township governments; Small businesses; For profit organizations other than small businesses; Private institutions o. Applications are accepted on a rolling basis. Apply via the official listing at www.grants.gov.
- Amount
- Up to $500K
- Deadline
- Rolling
- Type
- Competitive
- Status
- Forecasted
About this program
The NIH Common Fund, in partnership with other NIH Institutes and Centers, plans to issue Notices of Funding Opportunity (NOFOs) for the RNomics program, which seeks to develop tools for studying the full set of RNA molecules (the RNome) in cells and tissues. The program will support technologies and resources that enable integrated analysis of RNA sequences, modifications, structures, locations, interactions, and functions to advance understanding of health and disease. RNomics includes four initiatives: technology enhancement centers, transformative technologies, molecular standards, and a coordinating center. Applications are not being solicited at this time. This notice is being provided to give potential applicants time to develop meaningful collaborations and strong projects. This NOFO will support the transformative technologies initiative. These phased projects will develop new experimental and computational RNA technologies that address major limitations of current methods. Projects will focus on early-stage, high-risk ideas not yet demonstrated at scale or in biologically relevant systems. Priority areas include tools to sequence RNA, detect modifications, study RNA function, and analyze RNA across molecules, cells, and tissues. Projects that successfully complete Phase 1 milestones will be evaluated for transition to Phase 2. Phase 2 projects are expected to deliver validated tools for community use.
Who can apply
Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education; City or township governments; Small businesses; For profit organizations other than small businesses; Private institutions of higher education; Public and State controlled institutions of higher education; County governments; Independent school districts; Special district governments; Public housing authorities/Indian housing authorities; Others (see text field entitled "Additional Information on Eligibility" for clarification); Native American tribal governments (Federally recognized); Native American tribal organizations (other than Federally recognized tribal governments); Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education; State governments. Other Eligible ApplicantsIndian/Native American Tribal Governments (Other than Federally Recognized);Eligible Agencies of the Federal Government;U.S. Territory or Possession;Faith-based or Community-based Organizations;Regional Organizations;Non-domestic (non-U.S.) Entities (Foreign Institutions).
How to apply
Apply through Grants.gov using funding opportunity number RFA-RM-28-006. Register your organization (SAM.gov + Grants.gov) before the deadline, then submit the application package listed in the official notice.
Apply at official sourceRelated grants
- Mechanisms that Impact Cancer Risk after Bariatric Surgery (R21 Clinical Trial Not Allowed) NIH · See listing · Jan 7, 2028 Open
- RESTORE Act Direct Component - Non-Construction Activities USDOT · Up to $120.2M · Oct 31, 2026 Open
- Cannabis Research and Innovation Funding Opportunity (RIFO) Department of Fish and Wildlife · Dependant on number of submissions received, application process, etc. · Rolling Open
- Translational Efforts to Advance Gene-based Therapies for Ultra-Rare Neurological and Neuromuscular Disorders (U01 - Clinical Trial Optional) NIH · See listing · Oct 8, 2027 Open